• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Genetic modification of neural stem cells.

作者信息

Jandial Rahul, Singec Ilyas, Ames Christopher P, Snyder Evan Y

机构信息

Division of Neurological Surgery, University of California, San Diego, California, USA.

出版信息

Mol Ther. 2008 Mar;16(3):450-7. doi: 10.1038/sj.mt.6300402. Epub 2008 Feb 5.

DOI:10.1038/sj.mt.6300402
PMID:18253153
Abstract

Neural stem cells (NSCs) are the main vehicle for genetic and molecular therapies in the central nervous system (CNS). The sustainability of NSCs has been ensured through genetic manipulation both in vitro and in vivo. NSC lines have also been immortalized and controlled for cell growth in similar fashion. Their potential to differentiate and their genetic plasticity make them the modality of choice for cellular transplantation. After transplantation, NSCs also exhibit inherent long-distance migratory capabilities and a remarkable capacity to integrate into brain structures. This makes NSCs the ideal candidate for delivery and expression of therapeutic genes. Mouse models of CNS diseases have already demonstrated the efficacy of such NSC-mediated treatment, and further investigations are underway to bridge the gap into true clinical application. Finally, the imaging possibilities with NSC transplants are endless, and they will be a pivotal component to safe and effective human transplantation. This paper provides an overview on NSCs and the various methods in which they have been genetically manipulated for biological investigation.

摘要

相似文献

1
Genetic modification of neural stem cells.
Mol Ther. 2008 Mar;16(3):450-7. doi: 10.1038/sj.mt.6300402. Epub 2008 Feb 5.
2
Expression profile of an operationally-defined neural stem cell clone.一个操作定义的神经干细胞克隆的表达谱
Exp Neurol. 2005 Aug;194(2):320-32. doi: 10.1016/j.expneurol.2005.04.018.
3
Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: Evidence from engraftment of Neurotrophin-3-expressing stem cells in hypoxic-ischemic brain injury.神经干细胞可能特别适合联合基因治疗和细胞替代:来自在缺氧缺血性脑损伤中植入表达神经营养因子-3的干细胞的证据。
Exp Neurol. 2006 May;199(1):179-90. doi: 10.1016/j.expneurol.2006.03.016. Epub 2006 May 22.
4
Genetically engineered human neural stem cells for brain repair in neurological diseases.用于神经疾病脑修复的基因工程化人类神经干细胞
Brain Dev. 2007 May;29(4):193-201. doi: 10.1016/j.braindev.2006.07.012. Epub 2007 Feb 15.
5
Neural stem cells, neural progenitors, and neurotrophic factors.神经干细胞、神经前体细胞和神经营养因子。
Cell Transplant. 2007;16(2):133-50.
6
Combined transplantation of neural stem cells and olfactory ensheathing cells for the repair of spinal cord injuries.神经干细胞与嗅鞘细胞联合移植修复脊髓损伤
Med Hypotheses. 2007;69(6):1234-7. doi: 10.1016/j.mehy.2007.04.011. Epub 2007 Jun 4.
7
Immortalized neural stem cells differ from nonimmortalized cortical neurospheres and cerebellar granule cell progenitors.永生化神经干细胞与非永生化皮质神经球和小脑颗粒细胞祖细胞不同。
Exp Neurol. 2005 Aug;194(2):301-19. doi: 10.1016/j.expneurol.2004.07.011. Epub 2004 Oct 5.
8
Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes.可移植的人类神经干细胞对发育信号作出反应,替代神经元,并表达外源基因。
Nat Biotechnol. 1998 Nov;16(11):1033-9. doi: 10.1038/3473.
9
Stem cell biology of the central nervous system.中枢神经系统的干细胞生物学
J Neurosci Res. 2002 Sep 15;69(6):698-707. doi: 10.1002/jnr.10343.
10
Human fetal cortical and striatal neural stem cells generate region-specific neurons in vitro and differentiate extensively to neurons after intrastriatal transplantation in neonatal rats.人类胎儿皮质和纹状体神经干细胞在体外产生区域特异性神经元,并在新生大鼠纹状体内移植后广泛分化为神经元。
J Neurosci Res. 2006 Dec;84(8):1630-44. doi: 10.1002/jnr.21066.

引用本文的文献

1
Advanced hydrogel mesh platform with neural stem cells and human umbilical vein endothelial cells for enhanced axonal regeneration.搭载神经干细胞和人脐静脉内皮细胞的先进水凝胶网状平台,用于增强轴突再生。
APL Bioeng. 2025 Apr 1;9(2):026101. doi: 10.1063/5.0244057. eCollection 2025 Jun.
2
Advances in genetically modified neural stem cell therapy for central nervous system injury and neurological diseases.用于中枢神经系统损伤和神经疾病的转基因神经干细胞治疗进展
Stem Cell Res Ther. 2024 Dec 18;15(1):482. doi: 10.1186/s13287-024-04089-1.
3
Regulation of young-adult neurogenesis and neuronal differentiation by neural cell adhesion molecule 2 (NCAM2).
神经细胞黏附分子 2(NCAM2)对成年早期神经发生和神经元分化的调节。
Cereb Cortex. 2023 Oct 14;33(21):10931-10948. doi: 10.1093/cercor/bhad340.
4
Novel Approaches Used to Examine and Control Neurogenesis in Parkinson's Disease.用于研究和控制帕金森病神经发生的新方法。
Int J Mol Sci. 2021 Sep 4;22(17):9608. doi: 10.3390/ijms22179608.
5
Lentivirus vector‑mediated genetic manipulation of oncogenic pathways induces tumor formation in rabbit brain.慢病毒载体介导的致癌途径基因操作可诱导兔脑肿瘤形成。
Mol Med Rep. 2021 Jun;23(6). doi: 10.3892/mmr.2021.12061. Epub 2021 Apr 13.
6
Evaluation of the Neurogenic Potential in the Rat Inferior Colliculus from Early Postnatal Days Until Adulthood.评估大鼠下丘脑中的神经发生潜力:从出生后早期到成年期。
Mol Neurobiol. 2021 Feb;58(2):719-734. doi: 10.1007/s12035-020-02151-6. Epub 2020 Oct 3.
7
Neural Stem Cell Transplantation for Neurodegenerative Diseases.神经干细胞移植治疗神经退行性疾病。
Int J Mol Sci. 2020 Apr 28;21(9):3103. doi: 10.3390/ijms21093103.
8
Modern Trends for Peripheral Nerve Repair and Regeneration: Beyond the Hollow Nerve Guidance Conduit.周围神经修复与再生的现代趋势:超越空心神经导管
Front Bioeng Biotechnol. 2019 Nov 22;7:337. doi: 10.3389/fbioe.2019.00337. eCollection 2019.
9
Restoring Motor Neurons in Spinal Cord Injury With Induced Pluripotent Stem Cells.利用诱导多能干细胞修复脊髓损伤中的运动神经元
Front Cell Neurosci. 2019 Aug 16;13:369. doi: 10.3389/fncel.2019.00369. eCollection 2019.
10
CRISPR/Cas9 Genome Engineering in Engraftable Human Brain-Derived Neural Stem Cells.可移植的人源脑源性神经干细胞中的CRISPR/Cas9基因组工程
iScience. 2019 May 31;15:524-535. doi: 10.1016/j.isci.2019.04.036. Epub 2019 May 4.